These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25994030)

  • 1. Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus.
    Wu Y; Zhang F; Ma J; Zhang X; Wu L; Qu B; Xia S; Chen S; Tang Y; Shen N
    Arthritis Res Ther; 2015 May; 17(1):131. PubMed ID: 25994030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus.
    Wu GC; Li J; Leng RX; Li XP; Li XM; Wang DG; Pan HF; Ye DQ
    Oncotarget; 2017 Apr; 8(14):23650-23663. PubMed ID: 28423570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients.
    Fu Q; Chen X; Cui H; Guo Y; Chen J; Shen N; Bao C
    Arthritis Res Ther; 2008; 10(5):R112. PubMed ID: 18793417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linc8986 and linc0597 in plasma are novel biomarkers for systemic lupus erythematosus.
    Rong C; Xu H; Yan C; Wei F; Zhou H; Guan X
    Exp Ther Med; 2021 Nov; 22(5):1210. PubMed ID: 34584555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full high-throughput sequencing analysis of differences in expression profiles of long noncoding RNAs and their mechanisms of action in systemic lupus erythematosus.
    Ye H; Wang X; Wang L; Chu X; Hu X; Sun L; Jiang M; Wang H; Wang Z; Zhao H; Yang X; Wang J
    Arthritis Res Ther; 2019 Mar; 21(1):70. PubMed ID: 30836987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of long noncoding RNAs expression levels and their gene polymorphisms with systemic lupus erythematosus.
    Li J; Wu GC; Zhang TP; Yang XK; Chen SS; Li LJ; Xu SZ; Lv TT; Leng RX; Pan HF; Ye DQ
    Sci Rep; 2017 Nov; 7(1):15119. PubMed ID: 29123179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA Expression Profiles in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Emerging Biomarkers and Therapeutic Targets.
    Wu H; Chen S; Li A; Shen K; Wang S; Wang S; Wu P; Luo W; Pan Q
    Front Immunol; 2021; 12():792884. PubMed ID: 35003113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA expression profiles in neutrophils revealed potential biomarker for prediction of renal involvement in SLE patients.
    Cai B; Cai J; Yin Z; Jiang X; Yao C; Ma J; Xue Z; Miao P; Xiao Q; Cheng Y; Qin J; Guo Q; Shen N; Ye Z; Qu B; Ding H
    Rheumatology (Oxford); 2021 Apr; 60(4):1734-1746. PubMed ID: 33068407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Plasma Expression Profiles of Long Non-Coding RNAs Reveal Potential Biomarkers for Systemic Lupus Erythematosus.
    Wu GC; Hu Y; Guan SY; Ye DQ; Pan HF
    Biomolecules; 2019 May; 9(6):. PubMed ID: 31141998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of sTNF-R1 and linc0597 as indicators for disease activity and diagnosis of lupus nephritis.
    Zheng CZ; Yan WW; Luo YL; Wang TL; Shu YB
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5582-5591. PubMed ID: 32495893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of calreticulin expression with disease activity and organ damage in systemic lupus erythematosus patients.
    Wang Y; Xie J; Liu Z; Fu H; Huo Q; Gu Y; Liu Y
    Exp Ther Med; 2017 May; 13(5):2577-2583. PubMed ID: 28565882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus.
    Li H; Meng D; Jia J; Wei H
    Lipids Health Dis; 2021 Aug; 20(1):95. PubMed ID: 34461924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of reduced expression of lncRNA TUG1 in the peripheral blood of systemic lupus erythematosus patients.
    Cao HY; Li D; Wang YP; Lu HX; Sun J; Li HB
    Int J Rheum Dis; 2020 Mar; 23(3):428-434. PubMed ID: 31944629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of serum sCXCL16 in systemic lupus erythematosus; potential involvement in cutaneous and renal manifestations.
    Qin M; Guo Y; Jiang L; Wang X
    Clin Rheumatol; 2014 Nov; 33(11):1595-601. PubMed ID: 25015061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA expression profile and association with SLEDAI score in monocyte-derived dendritic cells from patients with systematic lupus erythematosus.
    Wang Y; Chen S; Chen S; Du J; Lin J; Qin H; Wang J; Liang J; Xu J
    Arthritis Res Ther; 2018 Jul; 20(1):138. PubMed ID: 29996948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the Relationship between lncRNA Gene Polymorphism and Systemic Lupus Erythematosus.
    Guan X; Liu D; Xing Y; Guan X
    Comput Math Methods Med; 2022; 2022():4446016. PubMed ID: 35265170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Liu ZC; Zhou QL; Li XZ; Yang JH; Ao X; Veeraragoo P; Zuo XX
    Cytokine; 2011 Mar; 53(3):295-300. PubMed ID: 21163672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
    J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.